Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhoon Yoo

Showing results (51-60 of 250) with videos related to

Pageof 25
Sort By:
Annals of Hematology|January 21, 2014
Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphomaChanghoon Yoo, Dok Hyun Yoon, Jae-Cheol Jo, et al.
Hepatology International|January 12, 2024
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinomaHyung-Don Kim, Young-Gyu Park, Sejin Kim, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2022
Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinomaSeung Hyuck Jeon, Yong Joon Lee, Hyung-Don Kim, et al.
Cancer Research and Treatment|June 15, 2018
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular CarcinomaChanghoon Yoo, Jihoon Kang, Ho Yeong Lim, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2010
Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancerYoon-Koo Kang, Min-Hee Ryu, Changhoon Yoo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 28, 2021
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer TreatmentSun Yoo, Danbi Lee, Ju Hyun Shim, et al.
Cancer Research and Treatment|January 10, 2021
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert OpinionChanghoon Yoo, Chung Ryul Oh, Seung-Tae Kim, et al.
Leukemia Research|August 6, 2010
BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicityJeong Eun Kim, Dae Ho Lee, Changhoon Yoo, et al.
Anticancer Research|February 4, 2019
Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic CancerSang Hyun Shin, Yejong Park, Dae Wook Hwang, et al.
Investigational New Drugs|January 15, 2011
Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposureChanghoon Yoo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Pageof 25

Showing results (51-60 of 250) with videos related to

Sort By:
Pageof 25
Annals of Hematology|January 21, 2014
Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphomaChanghoon Yoo, Dok Hyun Yoon, Jae-Cheol Jo, et al.
Hepatology International|January 12, 2024
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinomaHyung-Don Kim, Young-Gyu Park, Sejin Kim, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2022
Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinomaSeung Hyuck Jeon, Yong Joon Lee, Hyung-Don Kim, et al.
Cancer Research and Treatment|June 15, 2018
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular CarcinomaChanghoon Yoo, Jihoon Kang, Ho Yeong Lim, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2010
Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancerYoon-Koo Kang, Min-Hee Ryu, Changhoon Yoo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 28, 2021
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer TreatmentSun Yoo, Danbi Lee, Ju Hyun Shim, et al.
Cancer Research and Treatment|January 10, 2021
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert OpinionChanghoon Yoo, Chung Ryul Oh, Seung-Tae Kim, et al.
Leukemia Research|August 6, 2010
BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicityJeong Eun Kim, Dae Ho Lee, Changhoon Yoo, et al.
Anticancer Research|February 4, 2019
Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic CancerSang Hyun Shin, Yejong Park, Dae Wook Hwang, et al.
Investigational New Drugs|January 15, 2011
Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposureChanghoon Yoo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Pageof 25